Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 61 for migraine

Edit search filters
  1. A Study of Atrial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

    Jacksonville, FL

  2. Evaluation of Dual Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Atrial Fibrillation that Undergo a Percutaneous Coronary Intervention with Stenting (REDUAL-PCI)

    Scottsdale/Phoenix, AZ

  3. Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term

    Rochester, MN

  4. Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

    Rochester, MN

  5. Study of Treating Patients with Vestibular Schwannoma with Aspirin

    Rochester, MN

  6. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

    Rochester, MN

  7. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Jacksonville, FL

  8. Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

    La Crosse, WI, Albert Lea, MN, Eau Claire, WI, Mankato, MN, Rochester, MN

  9. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

    Rochester, MN

  10. Acute Stroke Or Transient Ischaemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer